Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults

Age and Ageing

Volumn 42, Issue 3, 2013, Pages 306-311

  Okusaga, Olaoluwa ^a   Stewart, Marlene C W ^b   Butcher, Isabella ^b   Deary, Ian ^b   Fowkes, F Gerry R ^b   Price, Jackie F ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cholesterol; Cognition; Hypertension; Older people; Smoking

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; AUDITORY VERBAL LEARNING TEST; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIGIT SYMBOL TEST; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; MENTAL DETERIORATION; MENTAL TEST; MILL HILL VOCABULARY SCALE; PRIORITY JOURNAL; RAVEN PROGRESSIVE MATRICE; RISK ASSESSMENT; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; VERBAL FLUENCY TEST;

AGE FACTORS; AGED; AGING; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHOLESTEROL; COGNITION; COGNITION DISORDERS; DIASTOLE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOLIPIDEMIC AGENTS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND; SMOKING;

EID: 84877039594     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afs193     Document Type: Article

References (30)

1. Spooner MH. Britain grappling with dementia prevalence. CMAJ 2009; 180: E13.
2. Bischkopf J, Busse A, Angermeyer MC. Mild cognitive impairment: a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand 2002; 106: 403-14.
3. Nguyen M. Nurse's assessment of caregiver burden. Medsurg Nurs 2009; 18: 147-51.
4. Lithell H, Hansson L, Skoog I et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-86.
5. Price JF, Stewart MC, Deary IJ et al. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ 2008; 337: a1198.
6. Cherbuin N, Reglade-Meslin C, Kumar R et al. Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord 2009; 28: 47-55.
7. Solomon A, Kareholt I, Ngandu TBM et al. Serum cholesterol changes after midlife and late-life cognition, twenty-one-year follow-up study. Neurology 2007; 68: 751-6.
8. Daviglus ML, Bell CC, Berrettini W et al. National Institutes of Health State-of-the-Science Conference statement: preventing Alzheimer disease and cognitive decline. Ann Intern Med 2010; 153: 176-81.
9. Emery CF, Huppert FA, Schein RL. Do pulmonary function and smoking behavior predict cognitive function? Finding from a British sample. Psychol Health 1997; 12: 265-75.
10. Benton D. Do low cholesterol levels slow mental processing? Psychosom Med 1995; 57: 50-3.
11. Raven J, Raven JC, Court JH. Manual for Raven's Progressive Matrices and Vocabulary Scales. Oxford: Oxford Psychologists Press, 1998.
12. Salthouse TA. Localizing age-related individual differences in a hierarchical structure. Intelligence 2004; 32: 541-61.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
14. Lezak MD. Neuropsychological Assessment. New York: Oxford University Press, 1995.
15. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation, 1981.
16. Norusis MJ. Factor Analysis in SPSS 15.0 Statistical Procedures Companion. New Jersey: Prentice Hall Inc, 2006, pp. 394-7.
17. Scottish Index of Multiple Deprivation. http://www.scotland.gov.uk/Topics/Statistics/Browse/Social-Welfare/TrendSIMD. (8 January 2012, date last accessed).
18. Deary IJ, Whalley LJ, Crawfor JR. An 'instantaneous' estimate of a lifetime's cognitive change. Intelligence 2004; 32: 113-9.
19. Van Exel E, de Craen JMA, Gusesekloo J et al. Association between high density lipoprotein and cognitive impairment in the oldest old. Ann Neurol 2002; 51: 716-21.
20. Anstey KJ, Lipnicki DM, Low L-F. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry. 2008; 16: 343-54.
21. Simons M, Keller P, De Strooper B et al. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998; 95: 6460-4.
22. Summers MJ, Oliver KR, Coombes JS, Fassett RG. Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial. Pharmacotherapy 2007; 27: 183-90.
23. McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database of Syst Rev 2009; 2: CD003160.
24. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4: 487-99.
25. Hannesdottir K, Nitkunan A, Charlton RA, Barrick TR, MacGregor GA, Markus HS. Cognitive impairment and white matter damage in hypertension: a pilot study. Acta Neurol Scand 2009; 119: 261-8.
26. Manolio TA, Olson J, Longstreth WT. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep 2003; 5: 255-61.
27. Obisesan TO. Hypertension and cognitive function. Clin Geriatr Med 2009; 25: 259-88.
28. Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr 2008; 8: 36-0.
29. Batty GD, Deary IJ, Benzeval M, Der G. Does IQ predict cardiovascular disease mortality as strongly as established risk factors? Comparison of effect estimates using the West of Scotland 'Twenty-07' cohort study. Eur J Cardiovasc Prev Rehabil 2010; 17: 24-7.
30. Abrous DN, Adriani W, Montaron M-F et al. Nicotine selfadministration impairs hippocampal plasticity. J Neurosci 2002; 22: 3656-62.